Home › Funds › Sanofi › ARTV

Sanofi position in ARTV

Latigo Biotherapeutics Inc · Health Care

Sanofi reported holding 672,778 shares of ARTV (Latigo Biotherapeutics Inc) in its Q3 2026 13F filing — a position valued at US$11.2M, representing 1.78% of its reported portfolio and ranking #11 among its reported holdings. Sanofi first reported this position in Q3 2026.

Latest position (Q3 2026)672.78K sh
Reported value held$11.24M
Portfolio Weight1.78%
First reportedQ3 2026
Last changeNew
Updated2026-11-05

Last updated: 2026-11-05 · Source: SEC EDGAR Form 13F-HR

How Sanofi's ARTV position evolved

Sanofi first disclosed a stake in ARTV in Q3 2026 at 672,778 shares (US$11.2M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 672.78K $11.24M New

About ARTV and 13F data

ARTV (Latigo Biotherapeutics Inc) is a Health Care company. 62 other funds we track also report a position in ARTV — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$174.2M), 5AM Venture Management, LLC (US$22.8M), Venrock Adviser, LLC (US$19.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ARTV

All ARTV fund holders →

FAQ

How long has Sanofi held ARTV?

Sanofi has disclosed ARTV holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Sanofi's current position in ARTV?

As of Q3 2026, Sanofi holds 672.78K shares of ARTV (Latigo Biotherapeutics Inc), valued at $11.24M, representing 1.78% of its reported portfolio and ranking #11.

Has Sanofi been buying or selling ARTV?

In the latest 13F filing (Q3 2026), Sanofi newly opened its position in ARTV.

Which other funds hold ARTV?

Other major institutional holders of ARTV include RA CAPITAL MANAGEMENT, L.P., 5AM Venture Management, LLC, Venrock Adviser, LLC, among 62 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.